title: In Reply.
authors.affiliation: Thoracic Oncology Unit/Instituto Nacional de Cancerología, Mexico City, Mexico.
authors.forename: Martha
authors.initials: M
authors.lastname: de la Torre-Vallejo
authors.affiliation: Thoracic Oncology Unit/Instituto Nacional de Cancerología, Mexico City, Mexico.
authors.forename: Jenny
authors.initials: J
authors.lastname: Turcott
authors.affiliation: Thoracic Oncology Unit/Instituto Nacional de Cancerología, Mexico City, Mexico.
authors.forename: Oscar
authors.initials: O
authors.lastname: Arrieta
authors.affiliation: Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Vickie
authors.initials: V
authors.lastname: Baracos
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D011799:Quinazolines